FDA Approval Could Send Mylan (MYL) to New High

Expect to see some heavy volume today on Mylan Inc. (Nasdaq: MYL) today. Mylan, Inc., one of the leading generic and specialty pharmaceutical companies worldwide, was granted tentative approval, under the President Obama’s Emergency Plan for AIDS Relief, from the FDA  for Abacavir Sulfate and Lamivudine Tablets, 60 mg/30 mg. Add MYL to your list of stocks to watch immediately.

Used for treating children with HIV/AIDS, approval of Abacavir ...

Continue Reading →
0